Clinical Trial: Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Follicular Lymphoma
Study Type: INTERVENTIONAL
Official Title: A Phase II Trial of Tazemetostat Plus Mosunetuzumab in Untreated Follicular Lymphoma
Brief Summary:
The goal of this study is to learn about the safety and effectiveness of the combination of tazemetostat pills in combination with mosunetuzumab injections for people with follicular lymphoma who haven't received treatment before.The investigators hypothesize that tazemetostat with mosunetuzumab has the potential to increase the efficacy of the product without compromising the safety.Tazemetostat is a drug that inhibits EZH2, an enzyme known to drive the development of B-cell lymphomas, and inhibiting it…
Read more